These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11392959)

  • 1. Prevention of pneumococcal disease among adults.
    Maxim RB
    Med Health R I; 2001 May; 84(5):174-5. PubMed ID: 11392959
    [No Abstract]   [Full Text] [Related]  

  • 2. Rethinking recommendations for use of pneumococcal vaccines in adults.
    Whitney CG; Schaffner W; Butler JC
    Clin Infect Dis; 2001 Sep; 33(5):662-75. PubMed ID: 11486289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevnar(tm): a pneumococcal conjugate vaccine for infants and young children.
    Brown A
    Issues Emerg Health Technol; 2001 Feb; (14):1-6. PubMed ID: 11902222
    [No Abstract]   [Full Text] [Related]  

  • 4. AAP technical report on the prevention of pneumococcal infections. American Academy of Pediatrics.
    Preboth M
    Am Fam Physician; 2001 Mar; 63(6):1223-4, 1229-30, 1232. PubMed ID: 11277556
    [No Abstract]   [Full Text] [Related]  

  • 5. Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention.
    Bridy-Pappas AE; Margolis MB; Center KJ; Isaacman DJ
    Pharmacotherapy; 2005 Sep; 25(9):1193-212. PubMed ID: 16164394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Considerations on pediatric pneumococcal infection in Navarra].
    Bernaola E; Herranz M; Clerigué N; Torroba L; Gil F; Gil-Setas A
    Rev Esp Quimioter; 2007 Mar; 20(1):143-9. PubMed ID: 17530048
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65.
    Whitney CG
    Geriatrics; 2003 Oct; 58(10):20-2, 25. PubMed ID: 14569639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update: pneumococcal polysaccharide vaccine usage--United States. Recommendations of the Immunization Practices Advisory Committee.
    Ann Intern Med; 1984 Sep; 101(3):348-50. PubMed ID: 6465703
    [No Abstract]   [Full Text] [Related]  

  • 9. Has the seven-valent pneumococcal conjugate vaccine had an impact on invasive pneumococcal disease in Western Australia?
    Giele C; Moore H; Bayley K; Harrison C; Murphy D; Rooney K; Keil AD; Lehmann D
    Vaccine; 2007 Mar; 25(13):2379-84. PubMed ID: 17064825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An expanded pneumococcal vaccine (prevnar 13) for infants and children.
    Med Lett Drugs Ther; 2010 Aug; 52(1345):67-8. PubMed ID: 20724965
    [No Abstract]   [Full Text] [Related]  

  • 11. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar).
    Isaacman DJ; Fletcher MA; Fritzell B; Ciuryla V; Schranz J
    Vaccine; 2007 Mar; 25(13):2420-7. PubMed ID: 17049677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing invasive pneumococcal disease in the elderly: a state-level analysis.
    McBean AM; Jung K; Hebert PL
    Vaccine; 2006 Jul; 24(27-28):5609-14. PubMed ID: 16725240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
    Adam D; Fehnle K
    Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumococcal vaccination in asthma.
    Rees PJ
    Int J Clin Pract; 2006 Nov; 60(11):1341-2. PubMed ID: 17073831
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
    Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
    Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing epidemiology of invasive pneumococcal disease in central Australia prior to conjugate vaccine: a 16-year study.
    Torzillo PJ; Morey F; Gratten M; Murphy D; Matters R; Dixon J
    Vaccine; 2007 Mar; 25(13):2375-8. PubMed ID: 17030079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza and pneumococcal disease: does vaccination make a difference?
    Clover RD
    Ethn Dis; 2002; 12(1):S2-36-8. PubMed ID: 11913637
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
    Melegaro A; Edmunds WJ
    Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.